S Gastrointestinal And Liver Disease 12th Edition |work| May 2026
Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition (2020)
Overview
Often referred to simply as Sleisenger and Fordtran’s, the 12th edition remains the definitive, encyclopedic reference for physicians, fellows, and residents in gastroenterology and hepatology. Published in 2020 by Elsevier, this two-volume set continues the legacy of providing comprehensive, evidence-based, and clinically actionable information on the entire spectrum of digestive disorders. The 12th edition arrives at a time of rapid advancements in gut microbiome research, immunotherapy for liver disease, and minimally invasive endoscopic techniques, all of which are thoroughly integrated into this update.
Comparison: 12th Edition vs. 11th Edition vs. Other GI Textbooks
| Feature | Sleisenger 12th | Yamada’s Textbook of Gastroenterology | Current Diagnosis & Treatment: Gastroenterology | | :--- | :--- | :--- | :--- | | Pages | ~2,800 | ~2,400 | ~800 | | Online access | Yes (videos + image library) | Yes | Limited | | Focus | Comprehensive, clinically oriented | Basic science + clinical | Quick reference, concise | | Publication year | 2024 (anticipated/current) | 2022 | 2023 | | Best for | Board prep, deep dives, specialist practice | Academic researchers | Residents, busy clinicians |
The 12th edition is guided by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox . Major updates include: US Elsevier Health New Clinical Discussions s gastrointestinal and liver disease 12th edition
of advanced endoscopic procedures, such as balloon dilatation and stent placement. Comprehensive Scope
New Editorial Team: The work is now guided by senior editors Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Comparison: 12th Edition vs
Content Blueprint: Gastrointestinal and Liver Disease, 12th Edition
Target Audience: Gastroenterologists, Hepatologists, Internal Medicine Physicians, GI Fellows, NPs/PAs in GI
Core Focus: Pathophysiology, evidence-based diagnosis, advanced therapeutics, emerging technologies
Defining Features of the 12th Edition (New Content Areas):
was released on December 10, 2025. As the definitive reference for gastroenterology and hepatology for over 50 years, this two-volume masterwork continues to provide comprehensive coverage of pathophysiology, diagnosis, and management. Key Updates and New Features Raymond T
Major Updates in the 12th Edition
Strengths: